PDC and COVID-19: In our cohort, Control-LS individuals had significantly higher median pDC frequencies (75% higher; median of 0.20, IQR: 0.097-0.38) compared to COVID-19 patients (median 0.05, IQR: 0.015-0.11, P<0.0001) (Figure 3B).